TRACON Pharmaceutical (TCON) Tops Q3 EPS by 40c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q3 EPS of $0.33, $0.40 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $493.26 million versus the consensus estimate of $3.55 million.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49